Jeffrey L. Adair, Co-Founder, CEO and Chief Technology Officer
Jeff Adair began his career as a medical device design engineer with Medical Dynamics in 1983. Jeff directed the engineering department at Medical Dynamics for the next 14 years and assumed the responsibilities associated with the design and development of electronic endoscopes and surgical camera systems. These systems were sold under the Medical Dynamics name as well as OEM systems for some of the largest endoscope companies in the world. Jeff was directly involved with the design and development of many of the innovative products including The 5990 Optical Catheter system, various generations of CCD based surgical camera systems, Xenon and various arc-lamp based light-sources. Jeff was instrumental in developing ground-breaking endoscopic platforms including fiber-based endoscopes for “office arthroscopy” and “office laparoscopy” as well as the industry’s first Electronic Video Laparoscope that integrated the CCD chip into the distal tip of the scope. Jeff also serves as a member of the Board of Directors.
John G. Adair, Co-Founder, Executive Chairman and Chief Financial Officer
John Adair currently serves as Executive Chairman and CFO of MIS. He previously served as the Company’s Co-Chief Executive Officer through December 2010. John Adair also served as VP-Finance for BaroFold, Inc., a VC-backed biopharmaceutical company focused on developing novel protein therapeutics and Dharmacon, Inc. (a subsidiary of Thermo Fisher Scientific), focused on delivering synthesized RNAi for the life science market. Prior to joining Dharmacon, Mr. Adair served as a Finance Director at Amgen, Inc. as well as Finance Director and Controller for Akzo-Nobel NV’s generic pharmaceutical division and Controller and Chief Accounting Officer for Medical Dynamics, Inc. (formerly a Nasdaq-traded medical device company). John Adair started his career as an accounting auditor and tax preparer at McGladrey & Pullen, the fifth largest U.S. provider of assurance, tax and consulting services. John Adair received his BS degree in Accounting from Colorado State University and his MS degree in Finance from the University of Colorado. Mr. Adair is a CPA.
David R. Stevens, PhD
Dr. Stevens is currently Executive Chairman of Cedus, Inc., a private development stage biopharmaceutical company, and also a board member of Poniard Pharmaceuticals, Inc., and Aqua Bounty Technologies, Inc., both public life science development stage companies. He was an advisor to Bay City Capital from 1999-2006. Dr. Stevens was previously President and CEO of Deprenyl Animal Health, Inc., a public veterinary pharmaceutical company, from 1990 to 1998, and Vice President, Research and Development, of Agrion Corp., a private biotechnology company, from 1986 to 1988. He began his career in pharmaceutical research and development at the former Upjohn Company, where he contributed to the preclinical evaluation of Xanax and Halcion. Dr. Stevens received BS and DVM degrees from Washington State University, and a Ph.D. in Comparative Pathology from the University of California, Davis. He is a Diplomate of the American College of Veterinary Pathologists. Dr. Stevens has worked in the pharmaceutical and biotechnology industries since 1978. He brings to the board a diversity of management, operational, and product development experience, including as the former chief executive officer of a public veterinary pharmaceutical company and as an active participant in the medical device industry. Dr. Stevens is an independent Director and Chairs the Compensation Committee.
Mr. Lowy joined the Micro-Imaging Board of Directors in 2011. He is an investor as well as Chairman of the RAL Group, LLC, a technology management consulting group. He has more than 30 years of experience managing and growing technology based global businesses.
Mr. Lowy serves on the Boards of a variety of Medical technology companies including The Intellitec Medical Institute, BiOpix Inc. and Helicos Biosciences. He served as the interim CEO of Helicos in 2009/10. Previous to that Mr. Lowy served as the President and CEO of Fisher Biosciences, a division of Fisher Scientific, Mr. Lowy was responsible for 14 business units with more than 5,000 employees in 56 locations in 100 countries around the world. Before joining Fisher Biosciences, Mr. Lowy was President of Global Connectivity Solutions for ADC Telecommunications. He also served as president and Chief Operating Officer at the KRONE Group where he was responsible for all facets of this global business unit. Mr. Lowy spent the first 15 years of his career in operations, technology and general management positions at GE Medical Systems where he was intimately involved with the development and commercialization of Computerized Tomography and Magnetic Resonance Systems. Mr. Lowy earned his Master of Business Administration from the University of Wisconsin and a bachelor’s of science degree in mechanical engineering from the University of New Hampshire. Mr. Lowy is an independent Director and a member of the Compensation Committee.
David W. Brenman advises the Company on business and legal matters. Since 1984 Mr. Brenman has served as President, Treasurer and Director of Genesis Solar Corporation. From 1987 to 1988, Mr. Brenman was a Vice President with Lloyds International Corporation, the merchant banking subsidiary of Lloyds Bank Plc. Prior to 1984, Mr. Brenman was an associate with the law firm of Brenman Raskin & Friedlob, P.C. of Denver, Colorado, where he specialized in the fields of taxation and securities law. Mr. Brenman received a B.A. in accounting from the University of Washington, a J.D. from the University of Denver, College of Law and an L.L.M. in taxation from New York University.